Literature DB >> 2147925

Regulation therapy by Castillo-Morales in children with Down syndrome: primary and secondary orofacial pathology.

G J Limbrock1, H Hoyer, H Scheying.   

Abstract

Since Castillo-Morales developed the Orofacial Regulation Therapy for children with Down syndrome in the mid 1970s, close observation of orofacial symptoms in the growing child has led to new findings. Primary orofacial signs are present at birth through age one; secondary alterations develop with untreated school-age children. A synopsis of the most important disorders in children with Down syndrome is given. Findings that relate to malfunction are summed up; these findings can be influenced by Orofacial Regulation Therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2147925

Source DB:  PubMed          Journal:  ASDC J Dent Child        ISSN: 1945-1954


  5 in total

1.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

2.  Short-term and long-term results after early treatment with the Castillo Morales stimulating plate. A longitudinal study.

Authors:  A Hohoff; U Ehmer
Journal:  J Orofac Orthop       Date:  1999       Impact factor: 1.938

Review 3.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

Review 4.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

5.  Modified bluegrass appliance: a nonpunitive therapy for thumb sucking in pediatric patients-a case report with review of the literature.

Authors:  Amish Diwanji; Preet Jain; Jigar Doshi; Prakash Somani; Dhaval Mehta
Journal:  Case Rep Dent       Date:  2013-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.